TBCE and metabolic dysfunction-associated steatotic liver disease: Importantly, KCs, including DAMs from NAFLD patients, respond to DPI by upregulating the transcription of glycolytic genes and downregulating the transcription of inflammatory genes, suggesting DPI is also effective at reprogramming the metabolism of human KCs.